A coagulation analyzer outage is rarely just an equipment problem. Specimens keep arriving, urgent requests need a response, and staff must decide which samples can wait, which require referral, and which can move to a backup method. A written downtime plan makes these decisions more consistent. Its value depends on details that are easy to overlook during normal operation: available reagents, validated applications, specimen transport, reporting units, and clear responsibility for communication.
The plan should reflect the laboratory’s actual capabilities. A second instrument does not provide useful backup if its application is unverified, its controls are expired, or only one person knows how to operate it. Likewise, a referral agreement is incomplete without a reliable transport route and a defined process for receiving results.
Define the point at which downtime begins
Not every analyzer warning requires a full service interruption. Staff need criteria for distinguishing a recoverable interruption from a failure that activates the contingency plan. Examples include repeated QC failure, an unresolved aspiration fault, loss of temperature control, unavailable critical consumables, or a laboratory information system outage that prevents safe result release.
Assign an authorized person to activate the plan and document the time, affected assays, specimens already in process, and immediate actions. Technical staff can continue troubleshooting, but the decision about service continuity should not depend on an open-ended promise that the instrument may restart soon. Establish a review time at which the next decision will be made.
Build an assay-specific service map
List the route for each test rather than labeling the entire coagulation service as available or unavailable. PT and APTT may be supported on a backup instrument while fibrinogen, TT, D-Dimer, FDP, or antithrombin require referral. Some assays may remain available on another validated platform within the same laboratory.
For every route, identify the method, required specimen, expected turnaround time, operating hours, and responsible contact. Include the minimum volume and any additional aliquot needed for transport. A clinician requesting a panel should receive a clear explanation when its components will follow different pathways or arrive at different times.
Keep the backup method ready for use
A backup application needs documented verification before an outage occurs. Confirm precision, comparison performance, reportable range where applicable, reference information, calibration requirements, and QC procedures. Maintain current application settings and identify the approved reagent and consumable combinations. Store instructions where staff can reach them even if the main network is unavailable.
Readiness also requires periodic operation. A rarely used instrument may develop maintenance or reagent issues that remain hidden until an emergency. Schedule checks appropriate to the equipment and assay, record operator competency, and review the stock required to sustain the expected downtime workload. Follow manufacturer instructions for storage, maintenance, and prepared-reagent stability.
Recognize differences between methods
Results from different reagent and analyzer combinations may not be interchangeable. PT and APTT clotting times can differ because of reagent responsiveness and application conditions. D-Dimer methods can use different units and decision limits. Moving a specimen to another platform therefore requires attention to the result’s method context, not simply successful aspiration.
Define how the laboratory will identify the backup method in the report, which reference information applies, and when an interpretive comment is appropriate. Where serial monitoring is involved, communicate the method change so that an analytical difference is not automatically interpreted as a biological change. The laboratory should not invent a conversion factor to force agreement.
Protect specimens during the interruption
Create a visible inventory of samples awaiting testing, including collection time, requested assays, priority, storage location, and transfer status. Apply the specimen stability and processing requirements of the intended method. Avoid a general assumption that every coagulation assay permits the same delay, temperature, or freeze-thaw history.
For referrals, use traceable labels and packaging, record dispatch time, and confirm receipt. Transport conditions should be agreed with the receiving laboratory before routine use. If a specimen no longer meets acceptance criteria, staff need a documented route for explaining the limitation and requesting recollection when appropriate. Repeatedly moving tubes between benches without a tracking record creates unnecessary risk.
Prepare for information-system downtime too
An operational analyzer is insufficient if sample identity, orders, or results cannot be managed safely. Define a temporary accession process, a controlled record of work performed, and an authorized method for communicating urgent results. Include recipient identification and read-back where required by local policy.
After systems recover, reconcile manual records against electronic orders and results. Prevent duplicate reports and make corrections traceable. Staff should know who checks the reconciliation and how unresolved discrepancies are escalated. A paper form can support this process, but it needs clear fields and document control rather than improvised notes.
Communicate useful service information
Notify the clinical teams affected by the interruption with the available tests, referral arrangements, expected delays, and the contact for urgent requests. Update them when the service route changes. A short, specific message is more useful than a general statement that the laboratory is experiencing technical difficulties.
Distributors and service providers can support continuity by maintaining escalation contacts, common spare parts, replacement consumables, and clear response expectations. Reagent suppliers should clarify emergency delivery options and the compatibility evidence for proposed alternatives. An urgent substitute still needs an appropriate technical assessment.
Control return to routine operation
Before releasing the repaired analyzer for patient testing, confirm that the fault is resolved, required maintenance is complete, calibration remains suitable, and QC meets the laboratory’s acceptance criteria. Additional checks should reflect the work performed and the possible effect of the fault. Review specimens and results that may have been affected before the interruption was recognized.
Close the event by reconciling outstanding requests, documenting service restoration, and reviewing delays, rejected samples, referral problems, and communication gaps. A short exercise between outages can test whether contact lists, stock, and instructions remain usable. Reliable backup testing is maintained through routine preparation long before the primary analyzer stops.